48 related articles for article (PubMed ID: 24638963)
1. EIF5A2 is a novel chemoresistance gene in breast cancer.
Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
Breast Cancer; 2015 Nov; 22(6):602-7. PubMed ID: 24638963
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder.
Luo JH; Hua WF; Rao HL; Liao YJ; Kung HF; Zeng YX; Guan XY; Chen W; Xie D
Cancer Sci; 2009 May; 100(5):896-902. PubMed ID: 19298601
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer.
Liang Y; Li Y; Song X; Zhang N; Sang Y; Zhang H; Liu Y; Chen B; Zhao W; Wang L; Guo R; Yu Z; Yang Q
Cancer Biol Ther; 2018 Feb; 19(2):120-131. PubMed ID: 29293402
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer.
Aguiari G; Crudele F; Taccioli C; Minotti L; Corrà F; Keillor JW; Grassilli S; Cervellati C; Volinia S; Bergamini CM; Bianchi N
Int J Biol Sci; 2022; 18(1):1-14. PubMed ID: 34975314
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of EIF5A2 in solid tumors: A meta-analysis and bioinformatics analysis.
Fang J; Yu T; Jiang X; Lu Y; Shang X; Shen H; Lu Y; Zheng J; Fu P
Open Med (Wars); 2024; 19(1):20240962. PubMed ID: 38770178
[TBL] [Abstract][Full Text] [Related]
6. Targeting eIF5A2 reduces invasion and reverses chemoresistance in SCC-9 cells
Gao J; Li P
Histol Histopathol; 2024 Apr; 39(4):463-470. PubMed ID: 37334930
[TBL] [Abstract][Full Text] [Related]
7. Novel roles of RNA-binding proteins in drug resistance of breast cancer: from molecular biology to targeting therapeutics.
Cen Y; Chen L; Liu Z; Lin Q; Fang X; Yao H; Gong C
Cell Death Discov; 2023 Feb; 9(1):52. PubMed ID: 36759501
[TBL] [Abstract][Full Text] [Related]
8. High eukaryotic initiation factor 5A2 expression predicts poor prognosis and may participate in the SNHG16/miR-10b-5p/EIF5A2 regulatory axis in head and neck squamous cell carcinoma.
Ye S; Wang D; Jin M; Du J; Chen X; Zhang H; Zhou C; Fang S; Liu K
J Clin Lab Anal; 2023 Jan; 37(1):e24820. PubMed ID: 36550070
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic initiation factor 5A2 mediates hypoxia-induced autophagy and cisplatin resistance.
Xu G; Chen H; Wu S; Chen J; Zhang S; Shao G; Sun L; Mu Y; Liu K; Pan Q; Li N; An X; Lin S; Chen W
Cell Death Dis; 2022 Aug; 13(8):683. PubMed ID: 35931669
[TBL] [Abstract][Full Text] [Related]
10. Evidence of antagonistic predictive effects of miRNAs in breast cancer cohorts through data-driven networks.
Miglioli C; Bakalli G; Orso S; Karemera M; Molinari R; Guerrier S; Mili N
Sci Rep; 2022 Mar; 12(1):5166. PubMed ID: 35338170
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor regulates eIF5A2 expression and promotes prostate cancer metastasis via EMT.
Zheng Y; Li P; Huang H; Ye X; Chen W; Xu G; Zhang F
Cell Death Discov; 2021 Dec; 7(1):373. PubMed ID: 34864817
[TBL] [Abstract][Full Text] [Related]
12. Interactions Between
Wang S; Cheng M; Zheng X; Zheng L; Liu H; Lu J; Liu Y; Chen W
Onco Targets Ther; 2020; 13():13159-13170. PubMed ID: 33380806
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy.
Tang Y; Chen K; Luan X; Zhang J; Liu R; Zheng X; Xie S; Ke H; Zhang X; Chen W
Int J Oncol; 2020 Dec; 57(6):1368-1380. PubMed ID: 33174013
[TBL] [Abstract][Full Text] [Related]
14. High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients.
Yang X; Amgad M; Cooper LAD; Du Y; Fu H; Ivanov AA
J Transl Med; 2020 Sep; 18(1):334. PubMed ID: 32873298
[TBL] [Abstract][Full Text] [Related]
15. Eukaryotic translation initiation factor 5A in the pathogenesis of cancers.
Ning L; Wang L; Zhang H; Jiao X; Chen D
Oncol Lett; 2020 Oct; 20(4):81. PubMed ID: 32863914
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of EIF5A2 Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
Lin YM; Chen ML; Chen CL; Yeh CM; Sung WW
Diagnostics (Basel); 2020 Jun; 10(7):. PubMed ID: 32605067
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA GAS6-AS1 acts as a ceRNA for microRNA-585, thereby increasing
Ai J; Sun J; Zhou G; Zhu T; Jing L
Cell Cycle; 2020 Apr; 19(7):742-757. PubMed ID: 32089066
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-33a-5p overexpression sensitizes triple-negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial-mesenchymal transition.
Guan X; Gu S; Yuan M; Zheng X; Wu J
Oncol Lett; 2019 Dec; 18(6):5986-5994. PubMed ID: 31788073
[TBL] [Abstract][Full Text] [Related]
19. Eukaryotic initiation factor 5A2 and human digestive system neoplasms.
Meng QB; Peng JJ; Qu ZW; Zhu XM; Wen Z; Kang WM
World J Gastrointest Oncol; 2019 Jun; 11(6):449-458. PubMed ID: 31236196
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
